Physician profile
Evan Nelson
NPI 1467195511
$766.82
in general payments reported to CMS, 2019-2025
9 companies · $717 in 2025
The $717 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $18.35 · 2024: $31.81 · 2025: $717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $243.95 | 2025 | |
| Medtronic, INC. | $129.99 | 2025 | Percept PC Brainsense |
| Pfizer INC. | $121.61 | 2025 | |
| Janssen Biotech, INC. | $118.02 | 2025 | |
| Ucb, INC. | $55.27 | 2025 | Fintepla |
| Jazz Pharmaceuticals INC. | $33.76 | 2023-2024 | Epidiolex |
| Teva Pharmaceuticals USA, INC. | $28.89 | 2025 | Austedo Xr |
| Biogen, INC. | $18.93 | 2025 | Leqembi |
| Ipsen Biopharmaceuticals, INC | $16.40 | 2024 | Dysport |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.